Skip to main content
Premium Trial:

Request an Annual Quote

Lion Enters Distribution Deal with BioCat

NEW YORK, July 26 – Lion Bioscience said Thursday it has granted BioCat the exclusive rights to distribute two of its products, arrayTAG cDNA clones and the corresponding annotation database, arrayBASE, in German-speaking areas in Europe.

"The distribution partnership with BioCat provides us with the chance to strengthen our position in the German, Swiss and Austrian life science research market," Daniel Keesman, vice president of global sales and marketing at Lion, said in a statement. 

Biocat is a specialized distributor of genomics and proteomics products.

Lion’s arrayTAG cDNA clones are designed for microarray applications while arrayBASE provides information about the arrayTAG clones.

Both companies are based in Heidelberg, Germany.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.